Correlation Between Spyre Therapeutics and SOUTHERN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and SOUTHERN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and SOUTHERN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and SOUTHERN CALIF EDISON, you can compare the effects of market volatilities on Spyre Therapeutics and SOUTHERN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of SOUTHERN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and SOUTHERN.

Diversification Opportunities for Spyre Therapeutics and SOUTHERN

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Spyre and SOUTHERN is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and SOUTHERN CALIF EDISON in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SOUTHERN CALIF EDISON and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with SOUTHERN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SOUTHERN CALIF EDISON has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and SOUTHERN go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and SOUTHERN

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the SOUTHERN. In addition to that, Spyre Therapeutics is 4.36 times more volatile than SOUTHERN CALIF EDISON. It trades about -0.28 of its total potential returns per unit of risk. SOUTHERN CALIF EDISON is currently generating about 0.23 per unit of volatility. If you would invest  7,539  in SOUTHERN CALIF EDISON on September 5, 2024 and sell it today you would earn a total of  240.00  from holding SOUTHERN CALIF EDISON or generate 3.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy72.73%
ValuesDaily Returns

Spyre Therapeutics  vs.  SOUTHERN CALIF EDISON

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
SOUTHERN CALIF EDISON 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SOUTHERN CALIF EDISON has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, SOUTHERN is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Spyre Therapeutics and SOUTHERN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and SOUTHERN

The main advantage of trading using opposite Spyre Therapeutics and SOUTHERN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, SOUTHERN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SOUTHERN will offset losses from the drop in SOUTHERN's long position.
The idea behind Spyre Therapeutics and SOUTHERN CALIF EDISON pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing